Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Aripiprazole in Patients With Acute Mania

ClinicalTrials.gov ID: NCT00095511

Public ClinicalTrials.gov record NCT00095511. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 10:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients With Bipolar I Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial is to test the safety \& efficacy of aripiprazole in patients with Bipolar Mania for a period of at least 12 weeks.

Study identification

NCT ID
NCT00095511
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
615 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2004
Primary completion
Apr 30, 2007
Completion
Apr 30, 2007
Last update posted
Nov 10, 2013

2004 – 2007

United States locations

U.S. sites
38
U.S. states
21
U.S. cities
38
Facility City State ZIP Site status
Local Institution Tuscaloosa Alabama
Local Institution Scottsdale Arizona
Local Institution Cerritos California
Local Institution Garden Grove California
Local Institution La Palma California
Local Institution Riverside California
Local Institution San Diego California
Local Institution Denver Colorado
Local Institution Middletown Connecticut
Local Institution New Haven Connecticut
Local Institution Bradenton Florida
Local Institution Kissimmee Florida
Local Institution Maitland Florida
Local Institution Augusta Georgia
Local Institution Honolulu Hawaii
Local Institution Chicago Illinois
Local Institution Hoffman Estates Illinois
Local Institution Indianapolis Indiana
Local Institution Louisville Kentucky
Local Institution New Orleans Louisiana
Local Institition Shreveport Louisiana
Local Institution Saint Charles Missouri
Local Institution Clementon New Jersey
Local Institution Cedarhurst New York
Local Institution Elmsford New York
Local Institution Holliswood New York
Local Institution Morganton North Carolina
Local Institution Raleigh North Carolina
Local Institution Cincinnati Ohio
Local Institution Cleveland Ohio
Local Institution Lyndhurst Ohio
Local Institution Oklahoma City Oklahoma
Local Institution Norristown Pennsylvania
Local Institution Philadelphia Pennsylvania
Local Institution Austin Texas
Local Institution Bellaire Texas
Local Institution Houston Texas
Local Institution Arlington Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00095511, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 10, 2013 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00095511 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →